The DOI matches its Crossref record.
Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5′-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide
Open accessAbstract
With the use of a continuous spectrophotometric assay and initial rates determined by the method of Waley [Biochem. J. (1981) 193, 1009-1012] methotrexate was found to be a non-competitive inhibitor, with Ki(intercept) = 72 microM and Ki(slope) = 41 microM, of 5-aminoimidazole-4-carboxamide ribotide transformylase, whereas a polyglutamate of methotrexate containing three gamma-linked glutamate residues was a competitive inhibitor, with Ki = 3.15 microM. Pentaglutamates of folic acid and 10-formylfolic acid were also competitive inhibitors of the transformylase, with Ki values of 0.088 and 1.37 microM respectively. Unexpectedly, the pentaglutamate of 10-formyldihydrofolic acid was a good substrate for the transformylase, with a Km of 0.51 microM and a relative Vmax. of 0.72, which compared favourably with a Km of 0.23 microM and relative Vmax. of 1.0 for the tetrahydro analogue. An analysis of the progress curve of the transformylase-catalysed reaction with the above dihydro coenzyme revealed that the pentaglutamate of dihydrofolic acid was a competitive product inhibitor, with Ki = 0.14 microM. The continuous spectrophotometric assay for adenosine deaminase based on change in the absorbance at 265 nm was shown to be valid with adenosine concentrations above 100 microM, which contradicts a previous report [Murphy, Baker, Behling & Turner (1982) Anal. Biochem. 122, 328-337] that this assay was invalid above this concentration. With the spectrophotometric assay, 5-aminoimidazole-4-carboxamide riboside was found to be a competitive inhibitor of adenosine deaminase, with (Ki = 362 microM), whereas the ribotide was a competitive inhibitor of 5′-adenylate deaminase, with Ki = 1.01 mM. Methotrexate treatment of susceptible cells results in (1) its conversion into polyglutamates, (2) the accumulation of oxidized folate polyglutamates, and (3) the accumulation of 5-aminoimidazole-4-carboxamide riboside and ribotide. The above metabolic events may be integral elements producing the cytotoxic effect of this drug by (1) producing tighter binding of methotrexate to folate-dependent enzymes, (2) producing inhibitors of folate-dependent enzymes from their tetrahydrofolate coenzymes, and (3) trapping toxic amounts of adenine nucleosides and nucleotides as a result of inhibition of adenosine deaminase and 5′-adenylate deaminase respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
Cronstein, B. N., Naime, D., & Ostad, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116884 · Cited by 679
Adenosine, an endogenous anti-inflammatory agent
Cronstein, B. N. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.1.5 · Cited by 633
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
Cronstein, B. N. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.3 · Cited by 535
Methotrexate an Old Drug with New Tricks
Bedoui, Y., Guillot, X., Sélambarom, J., Guiraud, P., Giry, C., Jaffar-Bandjee, M. C., Ralandison, S., & Gasque, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205023 · Cited by 471
Methotrexate mechanism in treatment of rheumatoid arthritis
Friedman, B., & Cronstein, B. (2019) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.07.004 · Cited by 439
Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
Gonen, N., & Assaraf, Y. G. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.07.002 · Cited by 437
Mechanisms of action of methotrexate
Genestier, L., Paillot, R., Quemeneur, L., Izeradjene, K., & Revillard, J.-P. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00189-2 · Cited by 424
Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers
Brown, P. M., Pratt, A. G., & Isaacs, J. D. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.175 · Cited by 382
Molecular basis of antifolate resistance
Assaraf, Y. G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9049-z · Cited by 338
Dervieux, T., Furst, D., Lein, D. O., Capps, R., Smith, K., Walsh, M., & Kremer, J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20460 · Cited by 337
Koźmiński, P., Halik, P. K., Chesori, R., & Gniazdowska, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103483 · Cited by 326
Cronstein, B. N., Eberle, M. A., Gruber, H. E., & Levin, R. I. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2441 · Cited by 332
Folylpolyglutamate Synthesis and Role in the Regulation of One-Carbon Metabolism
Shane, B. (1989) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60397-0 · Cited by 322
THE MECHANISM OF ACTION OF METHOTREXATE
Cronstein, B. N. (1997) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70358-6 · Cited by 312
Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications
Chattopadhyay, S., Moran, R. G., & Goldman, I. D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0343 · Cited by 281
Biochemical and Clinical Aspects of Methotrexate Neurotoxicity
Vezmar, S., Becker, A., Bode, U., & Jaehde, U. (2003) · Chemotherapy · doi:10.1159/000069773 · Cited by 267
Molecular therapeutics. Methotrexate and its mechanism of action
Cronstein, B. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391203 · Cited by 265
Morabito, L., Montesinos, M. C., Schreibman, D. M., Balter, L., Thompson, L. F., Resta, R., Carlin, G., Huie, M. A., & Cronstein, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1554 · Cited by 259
Visentin, M., Zhao, R., & Goldman, I. D. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.02.002 · Cited by 253
Zhao, R., & Goldman, I. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206946 · Cited by 253
Microbiome-generated antifolates.
London, R. E. (2026) · FEBS Letters · doi:10.1002/1873-3468.70252 · Cited by 1
Metadata
- Authors
- Baggott, J. E., Vaughn, W. H., & Hudson, B. B.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1986-05-15
- Volume
- 236
- Issue
- 1
- Pages
- 193-200
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W29771769
- Cited by
- 205
- References
- 0
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.